Accedi
Accedi
Oppure accedi con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registrati
Oppure accedi con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Home
  2. Azioni
  3. Regno Unito
  4. London Stock Exchange
  5. GSK plc
  6. Notizie
  7. Altre lingue
    GSK   GB00BN7SWP63

GSK PLC

(GSK)
  Rapporto
Tempo reale stimato Cboe Europe  -  17:30:00 06/02/2023
1458.80 GBX   +1.33%
14:57Cronache di Borsa - Lunedì 6 Febbraio
MS
03/02Cronache di Borsa - Venerdì 3 Febbraio
MS
02/02GSK plc sconsigliato da JPMorgan
MM
RiassuntoQuotazioniGraficiNotizieRatingCalendarioSocietąFinanzaConsensusRevisioniDerivatiFondi 
RiassuntoTutte le notizieRaccomandazione analistiAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settoreAnalisi MarketScreener
Notizie in altre lingue su GSK PLC
13:30Gsk: announces results from 17-year retrospective study on US clinical trial diversity
08:18MÄRKTE EUROPA/US-chinesische Spannungen und Zinssorgen belasten
03/02Gsk: morgan stanley cuts target price to 1485p from 1520p…
02/02GSK : le comprimé Jesduvroq approuvé dans l'anémie aux USA
02/02GSK plc - Benlysta granted Orphan Drug Designation by US FDA for the potential treatmen..
02/02Tranche Update on Quest Diagnostics Incorporated (N..
02/02Zahl stationärer Krebsbehandlungen auf tiefstem Stand seit 20 Jahren
02/02Gsk: FY 2022 results transcript
02/02Jesduvroq (daprodustat) approved by US FDA for anaemia of chronic kidney disease in ad..
02/02Benlysta granted Orphan Drug Designation by US FDA for the potential treatment of syste..
02/02GSK gets FDA approval for drug to treat anaemia in adults on dialysis
02/02Goldman Sachs cuts Standard Chartered
02/02GSK's Oral Anemia Drug for Dialysis Patients Secures First-in-Class US FDA Nod
02/02GSK plc Announces US Food and Drug Administration Approval of Jesduvroq (Daprodustat), ..
02/02Gsk: Jesduvroq (daprodustat) approved by US FDA for anaemia of chronic kidney disease in ..
02/02U.S. FDA approves GSK's anemia drug for patients on dialysis
02/02U.S. FDA approves new GSK's anemia drug
02/02Quest Diagnostics Incorporated announces an Increase in Equity Buyback
01/02Health Care Up After GSK Earnings -- Health Care Roundup
01/02Analysis-GSK gives few clues on plans to replenish medicine cabinet
01/02Ionis Earns $15 Million Milestone Payment as GSK Advances Bepirovirsen to Phase 3 Studi..
01/02LATE BRIEFING - Unternehmen und Märkte
01/02FTSE 100 Closes Down 0.1% as Market Awaits Fed -2-
01/02FTSE 100 Closes Down 0.1% as Market Awaits Fed Meeting
01/02Global markets live: AMD, Amgen, Electronic Arts, PayPal, Snap...
01/02MÄRKTE EUROPA/Kleines Plus vor Fed-Entscheid - Software AG schwach
01/02Presse Rundblick - Mittwoch, 1. Februar
01/02MÄRKTE EUROPA/Vorsichtig aufwärts vor Fed-Entscheid - Software AG schwach
01/02GSK's Treatment Candidate for Systemic Sclerosis Gets US FDA's Orphan Drug Designation
01/02Big pharma: GSK beats forecasts, but Novartis lags
01/02GSK : désignation de médicament orphelin de la FDA
01/02Dpa-AFX-Überblick: UNTERNEHMEN vom 01.02.2023 - 15.15 Uhr
01/02GSK plc Declares Fourth Interim Dividend for 2022, Payable on 13 April 2023; Provides D..
01/02Tesco Could Make Further Acquisitions Given -2-
01/02Tesco Could Make Further Acquisitions Given Robust Free Cash Flow
01/02Wall Street attend la Fed, l'Europe profite du ralentissement de l'inflation
01/02Point marchés-Wall Street attend la Fed, l'Europe profite du ralentissement de l'inflat..
01/02Fed Policy Announcement Eyed as Exchange-Traded Funds, Equity Futures Fall Pre-Bell Wed..
01/02MIDDAY BRIEFING - Unternehmen und Märkte
01/02MÄRKTE EUROPA/Vor Zinsentscheidungen abwartend - Software AG schwach
01/02Trending : GSK 4Q Earnings, Sales Beat Expectations
01/02European Midday Briefing: Investors Eye Fed Decision
01/02Vodafone's Europe woes, Darktrace in trouble: Marke..
01/02Restructuration pour Orpéa, record absolu pour Exxo..
01/02Sterling Should Rise if BOE Lifts Rates By 50Bp, Will Fall Sharply on 25Bp Increase
01/02GSK's Q4 Adjusted Earnings, Sales Increase; Issues 2023 Outlook
01/02Glaxo: Q4 Earnings Snapshot
01/02GSK: bénéfice 2022 dopé par la scission des soins grand public
01/02Stocks to Watch in Europe: GSK, Novartis, Novo Nordisk, BBVA, ..
01/02GSK : 4ème trimestre meilleur que prévu, confiance pour 2023
01/02British Drugmaker GSK Upbeat on 2023 Prospects Amid Expected Vaccines Boost
01/02GSK profit up; Vodafone growth slows; US Fed ahead
01/02Les marchés retiennent leur souffle, la Fed sous les projecteurs
01/02GSK profit grows as aims for first-ever approved RSV vaccine
01/02FTSE 100 Rises as Entain, Halma Rally
01/02Pharmakonzern GSK bleibt dank Impfstoffgeschäft optimistisch für 2023
01/02GSK fait mieux que prévu au quatrième trimestre
01/02L'optimisme de retour en Europe avant l'inflation et la Fed
01/02GSK profitiert von hoher Nachfrage nach Gürtelrose-Impfstoff
01/02GSK: bénéfice 2022 plus que triplé à 15 milliards de livres
01/02Sterling Faces Sustained Weakness on UK Growth Concerns
01/02L'optimisme de retour en Europe avant l'inflation et la Fed
01/02GSK 4Q Sales and Earnings Rose, Driven by Specialty Medicines, Vaccines -- Update
01/02GSK mit kräftigem Gewinnanstieg im Schlussquartal
01/02Gsk: FY 2022 results slides
01/02Gsk gagne 1,1% après la publication de ses résultats trimestriels
01/02CORRECT: Stocks open higher ahead of US Fed rate decision
01/02Pas de blague, hein ?
01/02GSK boekt minder kwartaalomzet
01/02Stocks called higher ahead of US Fed rate decision
01/02GSK 4Q Sales and Earnings Rose, Driven by Specialty Medicines, Vaccines
01/02CAC 40 : des prises d'initiative limitées avant la Fed
01/02British Drugmaker GSK's FY22 Profit Tops Estimates Amid Record Shingrix Sales
01/02US FDA Grants Orphan Drug Designation to GSK's Systemic Sclerosis Treatment
01/02En Direct des Marchés : Airbus, Orpea, Derichebourg, Bonduelle, GS..
01/02Gsk - gsk expects turnover and adjusted operating profit gro…
01/02Gsk - 2023 guidance at cer and excludes any contribution fro…
01/02Gsk - 2023 turnover expected to increase between 6% to 8%…
01/02Gsk - 2023 adjusted operating profit expected to increase be…
01/02Gsk plc - final results…
01/02Gsk - 13.75p dividend declared for q4 2022. no change to exp…
01/02Gsk- fy (not qtrly) covid-19 solutions (xevudy) sales…
01/02GSK reports Q4 profit, sales beat Wall Street estimates
01/02Gsk: 2022 ESG updates at a glance
01/02Gsk: FY 2022 results infographic
01/02GSK Says Benlysta Granted Orphan Drug Designation By FDA
01/02GSK reports Q4 profit, sales beat Wall Street estimates
01/02Gsk: delivers strong 2022 performance with full year sales of £29.3 billion +19% AER, +13..
01/02Earnings Flash (GSK.L) GSK Posts FY22 Revenue GBP29.32B
01/02Earnings Flash (GSK.L) GSK Reports FY22 EPS GBX109.2
01/02BOLETÍN MATINAL: 1 de febrero de 2023
01/02GSK plc Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31..
01/02GSK plc Provides Earnings Guidance for the Full Year 2023
01/02Point marchés-Hausse en vue en Europe avec l'espoir d'une accalmie sur les taux de la F..
01/02Stocks called up as all eyes on Fed decision
01/02Dax vor Fed-Entscheid zur Eröffnung höher erwartet
01/02MORNING BRIEFING - Deutschland/Europa
01/02Marketmind: Lights, camera, action
01/02EMEA Morning Briefing: Stocks Poised for a Mixed Start Ahead of Fed Decision
01/02TAGESVORSCHAU/Mittwoch, 1. Februar